Endothelial GLP-1 (Glucagon-Like Peptide 1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.

CONCLUSIONS: GLP-1R activation attenuates cardiovascular complications of arterial hypertension by reduction of vascular inflammation through selective actions requiring the endothelial but not the myeloid cell GLP-1R. PMID: 31747801 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31747801?dopt=Abstract

Source: Arteriosclerosis, Thrombosis and Vascular Biology - November 20, 2019 Category: Cardiology Authors: Helmstädter J, Frenis K, Filippou K, Grill A, Dib M, Kalinovic S, Pawelke F, Kus K, Kröller-Schön S, Oelze M, Chlopicki S, Schuppan D, Wenzel P, Ruf W, Drucker DJ, Münzel T, Daiber A, Steven S Tags: Arterioscler Thromb Vasc Biol Source Type: research